{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:36:17Z","timestamp":1789724177792,"version":"4.0.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province","award":["20220035"],"award-info":[{"award-number":["20220035"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objective<\/jats:title>\n<jats:p>This study aimed to use Mendelian randomization (MR) to investigate the potential causal association between inflammatory bowel disease (IBD) and autoimmune hepatitis (AIH).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Two-sample MR was performed to estimate the causal effect of IBD on AIH. The primary analysis employed the inverse variance weighted (IVW) method in univariable MR analysis, supplemented by additional methods including MR-Egger, weighted median, simple mode, and weighted mode. The <jats:italic>p<\/jats:italic> values were adjusted by FDR <jats:italic>p<\/jats:italic>-value adjustment. In the replication analysis, the primary IVW analysis was repeated and then pooled by meta-analysis. Sensitivity analyses were performed using Cochran\u2019s Q test, MR-Egger intercept test, MR-PRESSO, leave-one-out, and funnel plot analysis to evaluate the robustness of the MR findings. Additionally, multivariable MR (MVMR) was employed to estimate the direct causal effect of IBD on the risk of AIH.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>In univariable MR analysis, a significant positive causal association was observed between IBD (both Crohn\u2019s disease (CD) or ulcerative colitis (UC)) and the risk of AIH (for CD and AIH, the IVW odds ratio (OR) = 1.10, 95% confidence interval (CI) = 1.00\u20131.16, <jats:italic>P<\/jats:italic> = 0.045, <jats:italic>FDR P<\/jats:italic> = 0.045; for UC and AIH, the IVW OR = 1.07, 95% CI = 1.00\u20131.13, <jats:italic>P<\/jats:italic> = 0.038, <jats:italic>FDR P<\/jats:italic> = 0.076). Furthermore, no significant positive correlation between IBD and the risk of AIH (OR = 1.13, 95% CI = 0.94\u20131.35, <jats:italic>P<\/jats:italic> = 0.194). Sensitivity analysis revealed no pleiotropic bias. MVMR analysis further confirmed the direct causal effect of CD or UC on the risk of AIH after adjusting for the common risk factors (cigarettes per day and osteoporosis). In the replication analysis, the positive causal association between UC and the risk of AIH remain significant (the IVW odds ratio (OR) = 1.32, 95% CI = 1.18\u20131.48, <jats:italic>P<\/jats:italic> = 2.90E-06). While no significant positive association was observed between CD or IBD and the risk of AIH in the replication analysis, a suggestive positive association between the identified risk factors (UC, CD, and IBD) and the risk of AIH was detected in the meta-analysis (OR = 1.09, 95% CI = 1.05\u20131.13, P&lt;0.0001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This MR study revealed a positive impact of the identified risk factors (CD, UC and IBD) on the risk of AIH within the European population.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0305220","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T18:00:24Z","timestamp":1717783224000},"page":"e0305220","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-3380","authenticated-orcid":true,"given":"Gang","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"pone.0305220.ref001","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"L Muratori","year":"2023","journal-title":"BMJ"},{"key":"pone.0305220.ref002","doi-asserted-by":"crossref","first-page":"e00032","DOI":"10.14309\/ctg.0000000000000032","article-title":"Novel HLA Class I Alleles Outside the Extended DR3 Haplotype Are Protective against Autoimmune Hepatitis","volume":"10","author":"C Lammert","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"pone.0305220.ref003","doi-asserted-by":"crossref","first-page":"746436","DOI":"10.3389\/fimmu.2021.746436","article-title":"Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies","volume":"12","author":"M Vuerich","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0305220.ref004","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2005.02488.x","article-title":"Clinical features of type 1 autoimmune hepatitis in elderly Italian patients","volume":"21","author":"A Granito","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0305220.ref005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1210\/edrv-16-6-686","article-title":"The aging thyroid","volume":"16","author":"S Mariotti","year":"1995","journal-title":"Endocr Rev"},{"key":"pone.0305220.ref006","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","article-title":"Genetic distinctions between autoimmune hepatitis in Italy and North America","volume":"11","author":"P Muratori","year":"2005","journal-title":"World J Gastroenterol"},{"key":"pone.0305220.ref007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes","volume":"10","author":"LC Oliveira","year":"2011","journal-title":"Autoimmun Rev"},{"key":"pone.0305220.ref008","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3350\/cmh.2015.0040","article-title":"Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis","volume":"22","author":"SW Park","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"pone.0305220.ref009","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/hep.32591","article-title":"Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis","volume":"76","author":"C Harrington","year":"2022","journal-title":"Hepatology"},{"key":"pone.0305220.ref010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/HEP.0000000000000183","article-title":"Treatment of autoimmune hepatitis: Budesonide does not solve our problems","volume":"77","author":"S Steinmann","year":"2023","journal-title":"Hepatology"},{"key":"pone.0305220.ref011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cld.2023.07.001","article-title":"Treatment of Autoimmune Hepatitis","volume":"28","author":"A Goel","year":"2024","journal-title":"Clin Liver Dis"},{"key":"pone.0305220.ref012","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4254\/wjh.v13.i12.1956","article-title":"Liver manifestations and complications in inflammatory bowel disease: A review","volume":"13","author":"R Gaspar","year":"2021","journal-title":"World J Hepatol"},{"key":"pone.0305220.ref013","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3748\/wjg.14.331","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease","volume":"14","author":"R Saich","year":"2008","journal-title":"World J Gastroenterol"},{"key":"pone.0305220.ref014","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08916934.2020.1755964","article-title":"Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease","volume":"53","author":"T Hadley","year":"2020","journal-title":"Autoimmunity"},{"key":"pone.0305220.ref015","doi-asserted-by":"crossref","first-page":"1132072","DOI":"10.3389\/fimmu.2023.1132072","article-title":"Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review","volume":"14","author":"X Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"pone.0305220.ref016","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2169\/internalmedicine.8866-21","article-title":"A case of primary sclerosing cholangitis and autoimmune hepatitis overlapping syndrome complicated by ulcerative colitis","volume":"61","author":"T Suzuki","year":"2022","journal-title":"Intern Med"},{"key":"pone.0305220.ref017","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1038\/s41598-021-98843-7","article-title":"Hepatobiliary phenotype of individuals with chronic intestinal disorders","volume":"11","author":"J Voss","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0305220.ref018","doi-asserted-by":"crossref","first-page":"1049432","DOI":"10.3389\/fpsyt.2022.1049432","article-title":"Psychiatric traits and intracerebral hemorrhage: A Mendelian randomization study","volume":"13","author":"Q Wang","year":"2023","journal-title":"Front Psychiatry"},{"key":"pone.0305220.ref019","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/ijc.34228","article-title":"The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study","volume":"151","author":"J Xiong","year":"2022","journal-title":"Int J Cancer"},{"key":"pone.0305220.ref020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent Developments in Mendelian Randomization Studies","volume":"4","author":"J Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"},{"key":"pone.0305220.ref021","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3390\/nu13103539","article-title":"Fatty Acids and Frailty: A Mendelian Randomization Study","volume":"13","author":"Y Tomata","year":"2021","journal-title":"Nutrients"},{"key":"pone.0305220.ref022","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"CA Anderson","year":"2011","journal-title":"Nat Genet"},{"key":"pone.0305220.ref023","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"JZ Liu","year":"2015","journal-title":"Nat Genet"},{"key":"pone.0305220.ref024","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use","volume":"51","author":"M Liu","year":"2019","journal-title":"Nat Genet"},{"key":"pone.0305220.ref025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13059-020-02248-0","article-title":"The variant call format provides efficient and robust storage of GWAS summary statistics","volume":"22","author":"MS Lyon","year":"2021","journal-title":"Genome Biol"},{"key":"pone.0305220.ref026","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"S Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"pone.0305220.ref027","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"S Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"pone.0305220.ref028","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12967-022-03407-6","article-title":"Causal relationship between physical activity, leisure sedentary behaviors and COVID-19 risk: a Mendelian randomization study","volume":"20","author":"X Chen","year":"2022","journal-title":"J Transl Med"},{"key":"pone.0305220.ref029","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"J Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"pone.0305220.ref030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"S Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"pone.0305220.ref031","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator","volume":"40","author":"J Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"pone.0305220.ref032","doi-asserted-by":"crossref","first-page":"795049","DOI":"10.3389\/fgene.2022.795049","article-title":"A Mild Causal Relationship Between Tea Consumption and Obesity in General Population: A Two-Sample Mendelian Randomization Study","volume":"13","author":"C Li","year":"2022","journal-title":"Front Genet"},{"key":"pone.0305220.ref033","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/ng.3785","article-title":"Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer","volume":"49","author":"RL Milne","year":"2017","journal-title":"Nat Genet"},{"key":"pone.0305220.ref034","doi-asserted-by":"crossref","first-page":"1088778","DOI":"10.3389\/fimmu.2023.1088778","article-title":"Systemic inflammatory regulators and proliferative diabetic retinopathy: A bidirectional Mendelian randomization study","volume":"14","author":"Q Shi","year":"2023","journal-title":"Front Immunol"},{"key":"pone.0305220.ref035","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.3748\/wjg.v13.i46.6134","article-title":"Smoking in inflammatory bowel diseases: good, bad or ugly?","volume":"13","author":"PL Lakatos","year":"2007","journal-title":"World J Gastroenterol"},{"key":"pone.0305220.ref036","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000496935","article-title":"Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking","volume":"37","author":"R Even Dar","year":"2019","journal-title":"Dig Dis"},{"key":"pone.0305220.ref037","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"TL Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"},{"key":"pone.0305220.ref038","first-page":"e19276","article-title":"Resolution of Autoimmune Hepatitis Following Total Colectomy in Severe Ulcerative Colitis: A Rare Presentation Associated With Leaky Gut","volume":"13","author":"MA Heckroth","year":"2021","journal-title":"Cureus"},{"key":"pone.0305220.ref039","first-page":"54","article-title":"Liver biopsy in inflammatory bowel disease patients with sustained abnormal liver function tests: a retrospective single-center study","volume":"36","author":"E Dias","year":"2023","journal-title":"Ann Gastroenterol"},{"key":"pone.0305220.ref040","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.3390\/jcm10225359","article-title":"Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease-A Single Center Experience","volume":"10","author":"U Daniluk","year":"2021","journal-title":"J Clin Med"},{"key":"pone.0305220.ref041","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41927-021-00186-3","article-title":"Chronic recurrent multifocal osteomyelitis and primary sclerosing cholangitis with type 1 autoimmune hepatitis in a child with ulcerative colitis: a case report","volume":"5","author":"HY Ng","year":"2021","journal-title":"BMC Rheumatol"},{"key":"pone.0305220.ref042","doi-asserted-by":"crossref","first-page":"649376","DOI":"10.3389\/fgene.2021.649376","article-title":"Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis","volume":"12","author":"Y Xie","year":"2021","journal-title":"Front Genet"},{"key":"pone.0305220.ref043","doi-asserted-by":"crossref","first-page":"10950","DOI":"10.1038\/s41598-023-35785-2","article-title":"Causal associations between inflammatory bowel disease and primary biliary cholangitis: a two-sample bidirectional Mendelian randomization study","volume":"13","author":"J Zhao","year":"2023","journal-title":"Sci Rep"},{"key":"pone.0305220.ref044","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221115312","article-title":"Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations","volume":"15","author":"C Bezzio","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"pone.0305220.ref045","first-page":"768","article-title":"Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?)","volume":"51","author":"S Ozdil","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"pone.0305220.ref046","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s10620-015-3699-4","article-title":"Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease","volume":"60","author":"EM DeFilippis","year":"2015","journal-title":"Dig Dis Sci"},{"key":"pone.0305220.ref047","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"F Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"pone.0305220.ref048","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"EM Hennes","year":"2008","journal-title":"Hepatology"},{"key":"pone.0305220.ref049","doi-asserted-by":"crossref","first-page":"e000879","DOI":"10.1136\/bmjgast-2022-000879","article-title":"Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis","volume":"9","author":"C Saeki","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"pone.0305220.ref050","doi-asserted-by":"crossref","first-page":"102618","DOI":"10.1016\/j.autrev.2020.102618","article-title":"2020 international consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"S Moiseev","year":"2020","journal-title":"Autoimmun Rev"},{"key":"pone.0305220.ref051","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"MP Manns","year":"2010","journal-title":"Hepatology"},{"key":"pone.0305220.ref052","doi-asserted-by":"crossref","first-page":"102787","DOI":"10.1016\/j.autrev.2021.102787","article-title":"Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting","volume":"20","author":"A Granito","year":"2021","journal-title":"Autoimmun Rev"},{"key":"pone.0305220.ref053","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","article-title":"Diagnostic criteria of autoimmune hepatitis","volume":"13","author":"R Liberal","year":"2014","journal-title":"Autoimmun. Rev"},{"key":"pone.0305220.ref054","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"D Zauli","year":"1997","journal-title":"Hepatology"},{"key":"pone.0305220.ref055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41420-023-01666-w","article-title":"The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects","volume":"9","author":"C Li","year":"2023","journal-title":"Cell Death Discov"},{"key":"pone.0305220.ref056","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Y Wei","year":"2020","journal-title":"Gut"},{"key":"pone.0305220.ref057","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis","volume":"51","author":"T Liwinski","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0305220.ref058","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/apt.15795","article-title":"Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy?","volume":"52","author":"A Granito","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0305220.ref059","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.20788","article-title":"Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic","volume":"42","author":"D-P Bogdanos","year":"2005","journal-title":"Hepatology"},{"key":"pone.0305220.ref060","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and inflammatory bowel disease: a meta-analysis","volume":"81","author":"SS Mahid","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"pone.0305220.ref061","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ibd\/izaa152","article-title":"Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn\u2019s Disease and Ulcerative Colitis: A Mendelian Randomization Study","volume":"27","author":"AN Georgiou","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0305220.ref062","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.3390\/nu13124499","article-title":"Exercise and Nutrition Impact on Osteoporosis and Sarcopenia-The Incidence of Osteosarcopenia: A Narrative Review","volume":"13","author":"SK Papadopoulou","year":"2021","journal-title":"Nutrients"},{"key":"pone.0305220.ref063","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/intimm\/dxv015","article-title":"The aryl hydrocarbon receptor\/microRNA-212\/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis","volume":"27","author":"I Chinen","year":"2015","journal-title":"Int Immunol"},{"key":"pone.0305220.ref064","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"HSP de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T18:00:54Z","timestamp":1717783254000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305220"}},"subtitle":[],"editor":[{"given":"Alessandro","family":"Granito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0305220","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}